<?xml version="1.0" encoding="UTF-8"?>
<p>Vaccines and antiviral-drugs are considered as the most effective tools for fighting against viruses. Unfortunately, nearly all attempts to develop vaccines against ASFVs have failed to induce effective protection (
 <xref rid="ref-59" ref-type="bibr">Wang et al., 2018</xref>). Therefore, it is necessary to develop antiviral drugs against the virus. Previous studies have found several antiviral drugs which could possibly inhibit ASFV infection in vitro (
 <xref rid="ref-6" ref-type="bibr">Arabyan et al., 2019</xref>), including nucleoside analogs (
 <xref rid="ref-8" ref-type="bibr">Berry &amp; Kinsella, 2001</xref>), genistein (
 <xref rid="ref-5" ref-type="bibr">Arabyan et al., 2018</xref>), genkwanin (
 <xref rid="ref-28" ref-type="bibr">Hakobyan et al., 2019</xref>), Rifampicin (
 <xref rid="ref-15" ref-type="bibr">Dardiri, Bachrach &amp; Heller, 1971</xref>), fluoroquinolone (
 <xref rid="ref-42" ref-type="bibr">Mottola et al., 2013</xref>), sulfated polysaccharides (
 <xref rid="ref-24" ref-type="bibr">García-Villalón &amp; Gil-Fernández, 1991</xref>), lauryl gallate (
 <xref rid="ref-34" ref-type="bibr">Hurtado et al., 2008</xref>), stilbenes resveratrol (
 <xref rid="ref-23" ref-type="bibr">Galindo et al., 2011</xref>), oxyresveratrol (
 <xref rid="ref-23" ref-type="bibr">Galindo et al., 2011</xref>), histone deacetylases enzymes (HDACs) inhibitor (
 <xref rid="ref-20" ref-type="bibr">Frouco et al., 2017</xref>), small peptide inhibitors (
 <xref rid="ref-33" ref-type="bibr">Hernáez et al., 2010</xref>) and so on. This study computationally predicted several candidate drugs targeting the ASFV proteins and ASFV-interacting swine proteins, which may be helpful for the development of more effective drugs against the ASFV.
</p>
